Fever After International Travel

Clinical Pediatric Emergency Medicine

Volumn 9, Issue 4, 2008, Pages 250-257

  Cavagnaro, Christopher S ^a   Brady, KeriAnne ^a   Siegel, Cary ^a  

^a CHILDREN S HOSPITAL AT MONTEFIORE   (United States)

Author keywords

dengue; fever after travel; leptospirosis; malaria; rickettsiae; typhoid

Indexed keywords

AMOXICILLIN; AMPICILLIN; ANTIBIOTIC AGENT; ATOVAQUONE PLUS PROGUANIL; AZITHROMYCIN; CEFIXIME; CEFTRIAXONE; CHLORAMPHENICOL; CHLOROQUINE; CIPROFLOXACIN; COTRIMOXAZOLE; DOXYCYCLINE; MEFLOQUINE; OFLOXACIN; PENICILLIN G; QUININE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TETRACYCLINE;

ANAMNESIS; ARTICLE; CHILD; CLINICAL FEATURE; CLINICAL PROTOCOL; DENGUE; DIAGNOSTIC PROCEDURE; DISEASE SEVERITY; DRUG EFFICACY; FEVER; GEOGRAPHIC DISTRIBUTION; HUMAN; LEPTOSPIROSIS; MALARIA; MONOTHERAPY; NONHUMAN; PHYSICAL EXAMINATION; RICKETTSIOSIS; SYMPTOM; TRAVEL; TYPHOID FEVER;

EID: 56349134137     PISSN: 15228401     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cpem.2008.09.002     Document Type: Article

References (54)

1. United States Department of Transportation, Research and Innovative Technology Administration Bureau of Transportation Statistics. U.S. International Travel and Transportation Trends: 2006 Update (2006), Bureau of Transportation Statistics, Washington, DC. http://tinet.ita.doc.gov/view/f-2003-07-001/ Accessed 10/4/08
2. United States Department of Commerce, International Trade Administration, Office of Travel and Tourism. In-flight survey (2003), Office of Travel and Tourism Industries, Washington, DC. http://www.bts.gov/publications/us_international_travel_and_transportati on_trends/2006/index.html Accessed 10/4/08
3. Steffen R., Rickenbach M., Wilhelm U., et al. Health problems after travel to developing countries. J Infect Dis 156 (1987) 84-91
4. Hill D.R. Health problems in a large cohort of Americans traveling to developing countries. J Travel Med 7 (2000) 259-266
5. Wilson M.E., Weld L.H., Boggild A., et al. Fever in returned travelers: results from the GeoSentinel surveillance network. Clin Infect Dis 44 (2007) 1560-1568
6. Freedman D.O., Weld L.H., Kozarsky P.E., et al. Spectrum of disease and relation to place of exposure among ill returned travelers. N Engl J Med 354 (2006) 119-130
7. Centers for Disease Control and Prevention. Treatment of malaria (guidelines for clinicians). Available at. http://www.cdc.gov/malaria/diagnosis_treatment/tx_clinicians.htm Accessed 5-1-2008
8. Centers for Disease Control and Prevention. Travelers' Health. Available at:. http://wwwn.cdc.gov/travel/default.aspx Accessed 4-26-2008
9. Sethuraman U., and Kamat D. Management of child with fever after international travel. Clin Pediatr 46 (2007) 222-227
10. Ryan E.T., Wilson M.E., and Kain K.C. Illness after international travel. N Engl J Med 347 (2002) 505-516
11. American Academy of Pediatrics. Red Book: 2006 report of the Committee on Infectious Diseases (2006), American Academy of Pediatrics, Elk Grove Village (Ill)
12. Griffith K.S., Lewis L.S., Mali S., et al. Treatment of malaria in the United States. JAMA 297 (2007) 2264-2277
13. Thwing J., Skarbinski J., Newman R.D., et al. Malaria surveillance-United States, 2005. MMWR Surveill Summ 56 (2007) 24-40
14. O'Brien D., Tobin S., Brown G., et al. Fever in returned travelers: review of hospital admissions for a 3-year period. Clin Infect Dis 33 (2001) 603-609
15. Dorsey G., Gandhi M., Ouygi J.H., et al. Difficulties in the prevention, diagnosis and treatment of imported malaria. Arch Intern Med 160 (2000) 2505-2510
16. Singh K., Wester W.C., and Trenholme G.N. Problems in the therapy for imported malaria in the United States. Arch Intern Med 163 (2003) 2027-2030
17. Krause P.J. Malaria (Plasmodium). In: Behrman R.E., Kliegman R.M., and Jenson H.B. (Eds). Nelson's textbook of pediatrics. 17th ed. (2004), W.B. Saunders, Philadelphia (Pa) 1139-1143
18. Leggat P.A. Assessment of febrile illness in the returned traveler. Aus Fam Phys 36 (2007) 328-333
19. Gubler D.J. Dengue and dengue hemorrhagic fever. Clin Micribiol Rev 11 (1998) 480-496
20. Rush B. An account of the bilious remitting fever, as it appeared in Philadelphia in the summer and autumn of the year 1780. In: Rush B. (Ed). Medical inquiries and observations (1789), Prichard and Hall, Philadelphia (Pa) 104-117
21. Gibbons R.V., and Vaughn D.W. Dengue: an escalating problem. BMJ 324 (2002) 1563-1566
22. Gubler D.J. Epidemic dengue/dengue hemorrhagic fever as a public health, social and economic problem in the 21st century. Trends Microbiol 10 (2002) 100-103
23. Wilder-Smith A., and Schwartz E. Dengue in travelers. N Engl J Med 353 (2005) 924-932
24. Gubler D.J. The global emergence/resurgence of arboviral diseases as public health problems. Arch Med Res 33 (2002) 330-342
25. Guzman M.G., and Kouri G. Dengue: an update. Lancet Infect Dis 2 (2002) 33-42
26. Gubler D.J. Epidemic dengue and dengue hemorrhagic fever: a global public health problem in the 21st century. In: Scheld W.M., Armstrong D., and Hughes J.M. (Eds). Emerging infections Vol. 1 (1998), ASM Press, Washington, DC 1-14
27. Vaughn D.W., Green S., Kalayanarooj S., et al. Dengue in the early febrile phase: viremia and antibody responses. J Infect Dis 176 (1997) 322-330
28. Cobra C., Rigau-Perez J.G., Kuno G., et al. Symptoms of dengue fever in relation to host immunologic response and virus serotype, Puerto Rico, 1990-1991. Am J Epidemiol 142 (1995) 1204-1211
29. Deen J.L., Harris E., Willis B., et al. The WHO dengue classification and case definitions: time for a reassessment. Lancet 368 (2006) 170-173
30. World Health Organization. Dengue haemorrhagic fever: treatment. Available at:. http://www.who.int/csr/resources/publications/dengue/024-33.pdf Accessed 5-12-2008
31. Crump J.A., Luby S.P., and Mintz E.D. The global burden of typhoid fever. Bull World Health Org 82 (2004) 346-353
32. Aekers M.L., Puhr N.D., Tauxe R.V., et al. Laboratory based surveillance of Salmonella serotype Typhi infections in the United States. JAMA 283 (2000) 2668-2673
33. Parry C.M., Hien T.T., Dougan G., et al. Typhoid fever. N Engl J Med 347 (2002) 1770-1782
34. Bhutta Z.A. Impact of age and drug resistance on mortality in typhoid fever. Arch Dis Child 75 (1996) 214-217
35. van Basten J.P., and Stockenbrugger R. Typhoid perforation: a review of the literature since 1960. Trop Geograph Med 46 (1994) 336-339
36. Stephens I., and Levine M.M. Management of typhoid fever in children. Pediatr Infect Dis 21 (2002) 157-159
37. Wain J., Diep T.S., Ho V.A., et al. Quantitation of bacteremia in blood of typhoid fever patients and relationship between counts and clinical features, transmissibility, and antibiotic resistance. J Clin Microbiol 36 (1998) 1683-1687
38. Wain J., Bay V.B., Ha V., et al. Quantitation of bacteremia in bone marrow from patients with typhoid fever: relationship between counts and clinical features. J Clin Microbiol 39 (2001) 1571-1576
39. Bhutta Z.A. Current concepts in the diagnosis and treatment of typhoid fever. BMJ 333 (2006) 78-82
40. World Health Organization. Background document: the diagnosis, treatment and prevention of typhoid fever. Available at:. http://www.who.int/vaccine_research/documents/en/typhoid_diagnosis.pdf Accessed: 8-10-2008
41. Chapman A.S., Bakken J.S., Folk S.M., et al. Diagnosis and management of tickborne rickettsial diseases: Rocky Mountain spotted fever, ehrlichioses, and anaplasmosis-United States: a practical guide or physicians and other health-care and public health professionals. MMWR Recomm Rep 55 (2006) 1-27
42. Centers for Disease Control and Prevention. Traveler's health: yellow book, rickettsial infections. Available at:. http://wwwn.cdc.gov/travel/yellowBookCh4-Rickettsial.aspx Accessed: 5-21-2008
43. Rolain J.M., Jensenius M., and Raoult D. Rickettsial infections-a threat to travellers?. Curr Opin Infect Dis 17 (2004) 433-437
44. Bharti A.R., Nally J.E., Ricaldi J.N., et al. Leptospirosis: a zoonotic disease of global importance. Lancet Infect Dis 3 (2003) 757-771
45. McBride A.J.A., Athanazio D.A., Reis M.G., et al. Leptospirosis. Curr Opin Infect Dis 18 (2005) 376-386
46. Griffith M.E., Hospenthal D.R., and Murray C.K. Antimicrobial therapy of leptospirosis. Curr Opin Infect Dis 19 (2006) 533-537
47. Bovet P., Yersin C., Merein F., et al. Factors associated with clinical leptospirosis: a population-based case-control study in the Seychelles. Int J Epidemiol 28 (1999) 583-590
48. Levett P.N. Leptospirosis. Clin Microbiol Rev 14 (2001) 296-326
49. Vinetz J.M., Glass G.E., Flexner C.E., et al. Sporadic urban leptospirosis. Ann Intern Med 125 (1996) 794-798
50. Segura E.R., Ganoza C.A., Campos K., et al. Clinical spectrum of pulmonary involvement in leptospirosis in a region of endemicity, with quantification of leptospiral burden. Clin Infect Dis 40 (2005) 343-351
51. Watt G., Padre L., Tuazon M., et al. Placebo-controlled trial of intravenous penicillin for severe and late leptospirosis. Lancet 1 (1988) 433-435
52. World Health Organization. Human leptospirosis: guidance for diagnosis, surveillance and control (2003), World Health Organization, Geneva
53. Panaphut T., Domrongkitchaipom S., Vibhagool A., et al. Ceftriaxone compared with sodium penicillin G for treatment of severe leptospirosis. Clin Infect Dis 36 (2003) 1507-1513
54. Vinetz J. A mountain out of a molehill: do we treat acute leptospirosis, and if so, with what?. Clin Infect Dis 36 (2003) 1514-1515